(Q43449610)

English

Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b

scientific article published on 6 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 November 2017

Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b (English)

1 reference

Europe PubMed Central

23 November 2017

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

23 November 2017

author name string

Dorothy Ngo-Yin Fan

1

1 reference

Europe PubMed Central

23 November 2017

Felice Ho-Ching Tsang

2

1 reference

Europe PubMed Central

23 November 2017

Aegean Hoi-Kam Tam

3

1 reference

Europe PubMed Central

23 November 2017

Sandy Leung-Kuen Au

4

1 reference

Europe PubMed Central

23 November 2017

Carmen Chak-Lui Wong

5

1 reference

Europe PubMed Central

23 November 2017

Lai Wei

6

1 reference

Europe PubMed Central

23 November 2017

Joyce Man-Fong Lee

7

1 reference

Europe PubMed Central

23 November 2017

Irene Oi-Lin Ng

9

1 reference

Europe PubMed Central

23 November 2017

Chun-Ming Wong

10

1 reference

Europe PubMed Central

23 November 2017

language of work or name

0 references

publication date

6 December 2012

1 reference

Europe PubMed Central

23 November 2017

1 reference

Europe PubMed Central

23 November 2017

57

1 reference

Europe PubMed Central

23 November 2017

2

1 reference

Europe PubMed Central

23 November 2017

637-647

1 reference

Europe PubMed Central

23 November 2017

Hepatocellular carcinoma pathogenesis: from genes to environment

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Perceptions of epigenetics

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Global levels of histone modifications predict prostate cancer recurrence.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Global histone modification patterns predict risk of prostate cancer recurrence

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Global histone modifications predict prognosis of resected non small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Global histone modification of histone H3 in colorectal cancer and its precursor lesions.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Sequential alterations of microRNA expression in hepatocellular carcinoma development and venous metastasis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Association of the SUV39H1 histone methyltransferase with the DNA methyltransferase 1 at mRNA expression level in primary colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Restricted heterochromatin formation links NFATc2 repressor activity with growth promotion in pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

21 January 2018

Molecular pathogenesis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinicopathologic significance of genetic alterations in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

7 January 2021

based on heuristic

inferred from DOI database lookup

High frequency of p16INK4A gene alterations in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

7 January 2021

based on heuristic

inferred from DOI database lookup

The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

7 January 2021

based on heuristic

inferred from DOI database lookup

Epigenetic and genetic alterations of PTEN in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

7 January 2021

based on heuristic

inferred from DOI database lookup

Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.26083

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.26083

1 reference

Europe PubMed Central

23 November 2017

1 reference

Europe PubMed Central

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43449610&oldid=1989067271"